These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16783830)
1. Permanent unilateral hearing loss after radiotherapy for parotid gland tumors. van der Putten L; de Bree R; Plukker JT; Langendijk JA; Smits C; Burlage FR; Leemans CR Head Neck; 2006 Oct; 28(10):902-8. PubMed ID: 16783830 [TBL] [Abstract][Full Text] [Related]
2. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342 [TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss. Lamers-Kuijper E; Schwarz M; Rasch C; Mijnheer B Med Dosim; 2007; 32(4):237-45. PubMed ID: 17980823 [TBL] [Abstract][Full Text] [Related]
4. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819 [TBL] [Abstract][Full Text] [Related]
5. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836 [TBL] [Abstract][Full Text] [Related]
6. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858 [TBL] [Abstract][Full Text] [Related]
7. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose. Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646 [TBL] [Abstract][Full Text] [Related]
8. Temporal bone osteoradionecrosis after surgery and radiotherapy for malignant parotid tumors. Leonetti JP; Marzo SJ; Zender CA; Porter RG; Melian E Otol Neurotol; 2010 Jun; 31(4):656-9. PubMed ID: 20964249 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors. Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315 [TBL] [Abstract][Full Text] [Related]
10. Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects. Jereczek-Fossa BA; Rondi E; Zarowski A; D'Onofrio A; Alterio D; Ciocca M; Bianchi LC; Krengli M; Calabrese L; Ansarin M; Giugliano G; Orecchia R Strahlenther Onkol; 2011 Jun; 187(6):350-6. PubMed ID: 21603994 [TBL] [Abstract][Full Text] [Related]
11. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function. Ortholan C; Chamorey E; Benezery K; Thariat J; Dassonville O; Poissonnet G; Bozec A; Follana P; Peyrade F; Sudaka A; Gerard JP; Bensadoun RJ Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):178-86. PubMed ID: 18565687 [TBL] [Abstract][Full Text] [Related]
12. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923 [TBL] [Abstract][Full Text] [Related]
13. A prospective study on radiation-induced changes in hearing function. Herrmann F; Dörr W; Müller R; Herrmann T Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1338-44. PubMed ID: 16863923 [TBL] [Abstract][Full Text] [Related]
14. Results of exploratory tympanotomy following sudden unilateral deafness and its effects on hearing restoration. Maier W; Fradis M; Kimpel S; Schipper J; Laszig R Ear Nose Throat J; 2008 Aug; 87(8):438-51. PubMed ID: 18712692 [TBL] [Abstract][Full Text] [Related]
15. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy. Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355 [TBL] [Abstract][Full Text] [Related]
16. Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005. Bhide SA; Miah A; Barbachano Y; Harrington KJ; Newbold K; Nutting CM Br J Oral Maxillofac Surg; 2009 Jun; 47(4):284-9. PubMed ID: 19193477 [TBL] [Abstract][Full Text] [Related]
17. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018 [TBL] [Abstract][Full Text] [Related]
18. Quality of life after parotid and temporal bone surgery for cancer. Kwok HC; Morton RP; Chaplin JM; McIvor NP; Sillars HA Laryngoscope; 2002 May; 112(5):820-33. PubMed ID: 12150613 [TBL] [Abstract][Full Text] [Related]
19. Radiation dose to otologic structures during head and neck cancer radiation therapy. Ondrey FG; Greig JR; Herscher L Laryngoscope; 2000 Feb; 110(2 Pt 1):217-21. PubMed ID: 10680919 [TBL] [Abstract][Full Text] [Related]
20. Elective parotidectomy in the management of advanced auricular malignancies. Osborne RF; Shaw T; Zandifar H; Kraus D Laryngoscope; 2008 Dec; 118(12):2139-45. PubMed ID: 19029866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]